The cementless total knee arthroplasty Market was valued for $1.93 billion in 2022 and is estimated to reach $3.03 billion by 2032, exhibiting a CAGR of 4.6% from 2023 to 2032. Cementless knee implants, also known as press-fit knee implants, have a rough, porous surface that encourages new bone growth. The new bone grows into the spaces in the implant, holding it in place without the need for cement. The bones within the knee are shaped with special tools so that they fit snugly with the implant. In some cases, screws may be used to hold the prosthetics in place while the bone grows. Currently, cementless implants are only available for total knee replacements.
Major factors that drive the growth of the global cementless total knee arthroplasty market include increase in prevalence of rheumatoid arthritis and sports-related injuries, technological advancement in implant designs, materials, and surgical techniques that has significantly improved the outcomes of cementless knee arthroplasty. For instance, according to the report published by Global RA Network, in 2021, it has been reported that more than 350 million people have arthritis globally in which up to 3% of the global population has psoriatic arthritis and 14 million people have rheumatoid arthritis.,
Furthermore, the surge in the number of R&D activities for the development of technologically advanced medical devices used in knee arthroplasty and rapidly growing geriatric population are the factors that propel the growth of the market. In addition, the advantage of cementless knee arthroplasty over cemented implants such as better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries leading to a shift toward cementless knee arthroplasty that increases the adoption of the cementless total knee arthroplasty platforms, thus propelling the market growth.
However, the high cost associated with cementless knee arthroplasty implants and easy availability of alternatives such as cemented knee arthroplasty are the major barriers to the growth of the market. On the contrary, growing patients' preference for cementless implants and favorable reimbursement policies and insurance coverage for cementless knee arthroplasty procedures are expected to offer remunerative opportunities for the expansion of the global cementless total knee arthroplasty market in the future.
The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV. The major players in the market have adopted product launch and innovation as key developmental strategies to improve the product portfolio of the cementless total knee arthroplasty market.
Major factors that drive the growth of the global cementless total knee arthroplasty market include increase in prevalence of rheumatoid arthritis and sports-related injuries, technological advancement in implant designs, materials, and surgical techniques that has significantly improved the outcomes of cementless knee arthroplasty. For instance, according to the report published by Global RA Network, in 2021, it has been reported that more than 350 million people have arthritis globally in which up to 3% of the global population has psoriatic arthritis and 14 million people have rheumatoid arthritis.,
Furthermore, the surge in the number of R&D activities for the development of technologically advanced medical devices used in knee arthroplasty and rapidly growing geriatric population are the factors that propel the growth of the market. In addition, the advantage of cementless knee arthroplasty over cemented implants such as better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries leading to a shift toward cementless knee arthroplasty that increases the adoption of the cementless total knee arthroplasty platforms, thus propelling the market growth.
However, the high cost associated with cementless knee arthroplasty implants and easy availability of alternatives such as cemented knee arthroplasty are the major barriers to the growth of the market. On the contrary, growing patients' preference for cementless implants and favorable reimbursement policies and insurance coverage for cementless knee arthroplasty procedures are expected to offer remunerative opportunities for the expansion of the global cementless total knee arthroplasty market in the future.
The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV. The major players in the market have adopted product launch and innovation as key developmental strategies to improve the product portfolio of the cementless total knee arthroplasty market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cementless total knee arthroplasty market analysis from 2022 to 2032 to identify the prevailing cementless total knee arthroplasty market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cementless total knee arthroplasty market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cementless total knee arthroplasty market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update (only available with the purchase of an enterprise license)
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
- 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
- Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
- Free report update, if the report is 6-12 months old or older.
- 24-hour priority response
- Free industry updates and white papers.
Key Market Segments
By Product
- Mobile Bearings
- Fixed Bearings
By Material
- Ceramics
- Alloy
- Others
By End User
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- B. Braun Melsungen AG
- Johnson & Johnson
- MicroPort Scientific Corporation
- Olympus Corporation
- Smith & Nephew plc
- Stryker Corporation.
- United Orthopedic Corporation
- Waldemar Link GmbH & Co. KG
- X. NOV
- Zimmer Biomet Holding Inc.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT
CHAPTER 5: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL
CHAPTER 6: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER
CHAPTER 7: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to this report, the cementless total knee arthroplasty market was valued at $1.9 billion in 2022, and is estimated to reach $3 billion by 2032, growing at a CAGR of 4.6% from 2023 to 2032.Cementless implants have shown to reduce the prevalence of radiological radiolucent lines (RLL), which may help to improve implant survivorship and reduce revision rates compared to cemented implants for uni-compartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA). These advantages have led to a number of high-volume centers selecting cementless over cemented UKA, with excellent patient-reported outcomes and implant survivorship of over 97% at minimum ten years follow-up.
Key factors driving the growth of the cementless total knee arthroplasty market include rise in prevalence of knee osteoarthritis, technological advancements in cementless knee implants and rise in number of sports related injuries and road-accidents.
People are becoming more conscious about maintaining an active and healthy lifestyle, even as they age. Cementless knee arthroplasty allows individuals to regain knee function and engage in activities such as sports, exercise, and recreational pursuits. The desire to maintain an active lifestyle fuels the demand for knee arthroplasty procedures, driving market growth.
In addition, surge in prevalence of knee osteoarthritis and rheumatoid arthritis and increase in the number of procedures of total knee replacement are the major factors that increases the demand for cementless total knee arthroplasty implants and hence propel the growth of the market. For instance, according to a report published by Osteoarthritis Foundation International in 2021, worldwide, an estimated 500 million people have osteoarthritis, whereas more than 32.5 million U. S. adults have osteoarthritis out of which 62% of people with osteoarthritis are women and more than 22% of adults around the world who are older than 40 have knee osteoarthritis. In Spain the figure is of 7 million patients. In addition, it is the main cause of permanent disability and the third cause of temporary working place disability.
Furthermore, the rise in obesity rates is a substantial risk factor for conditions affecting the knee joints, such as osteoarthritis. The number of people needing knee replacement surgery is rising along with the global incidence of obesity. For instance, according to a research released by the International Diabetes Federation in 2021, roughly 537 million individuals (20-79 years) currently have diabetes. However, by 2030 and 2045, it is anticipated that this number would increase to 643 million and 783 million, respectively. In light of its enhanced stability and long-term durability, cementless knee arthroplasty offers an effective treatment for obese patients and is anticipated to drive the market's expansion.
Moreover, advancements in technologies, such as continuous development of advanced implant designs, materials, and surgical techniques have significantly improved the outcomes of cementless knee arthroplasty. These advancements offer benefits such as improved longevity, better range of motion, reduced complications, and faster recovery. Technological innovations attract both patients and surgeons, thereby driving the market growth. For instance, in November 2022, Zimmer Biomet Holdings, Inc. announced U. S. Food and Drug Administration (FDA) 510(k) clearance for the Persona OsseoTi Keel Tibia for cementless knee replacement. Persona OsseoTi is the latest addition to the clinically proven Persona knee system and features a new porous version of the Persona anatomic tibia with Zimmer Biomet's OsseoTi Porous Metal Technology.
In addition, the introduction of minimally invasive surgical approaches has facilitated shorter hospital stays, reduced complications, and faster rehabilitation, making cementless knee arthroplasty more appealing to patients and surgeons. Thus, all these factors collectively are anticipated to boost the growth of the market.
The market also offers growth opportunities to the key players in the market. Cementless knee arthroplasty offers certain advantages over the traditional cemented approach. These advantages include better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries. Surgeons and patients are increasingly recognizing these benefits, leading to a shift toward cementless knee arthroplasty, which is expected to provide lucrative opportunities for market growth.
Furthermore, increased awareness campaigns about knee joint diseases, treatment options, and the benefits of cementless knee arthroplasty can encourage patients to seek appropriate medical interventions. Patient education initiatives can help individuals make informed decisions about their healthcare, leading to increased demand for cementless knee arthroplasty. Thus, this accelerating change offers an opportunity for key market players to invest in cementless total knee arthroplasty devices, which boosts the growth of the market. All these factors, collectively, are expected to open new avenues for the growth of the cementless total knee arthroplasty during the forecast period.
The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV.
Key Market Insights
By product, the fixed bearings segment is expected to experience rapid growth in the market and is estimated to reach $2.52 billion by 2032, with a CAGR of 4.8%. However, the mobile bearings segment is estimated to be growing with a significant CAGR of 3.7% during the forecast period.By material, the alloy segment dominated the global market. However, the others segment is expected to grow with a significant CAGR of 4.6% during the forecast period.
By end user, the hospitals segment dominated the global market. However, the others segment is expected to grow with a fastest CAGR of 5.5% during the forecast period.
Based on region, North America garnered the largest revenue share in 2022, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 5.5% during the forecast period.
Companies Mentioned
- B. Braun Melsungen AG
- Johnson & Johnson
- MicroPort Scientific Corporation
- Olympus Corporation
- Smith & Nephew plc
- Stryker Corporation.
- United Orthopedic Corporation
- Waldemar Link GmbH & Co. KG
- X. NOV
- Zimmer Biomet Holding Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
